Resources from the same session
1925MO - Regomune study: A phase II study of regorafenib + avelumab in solid tumors. Results of the radioiodine-refractory differentiated thyroid cancer (RR-DTC)
Presenter: Sophie Cousin
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1926MO - Radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients treated with lenvatinib monotherapy: Real-world treatment patterns and clinical outcomes in Europe and Canada
Presenter: Laura Locati
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 1925MO and 1926MO
Presenter: Sophie Leboulleux
Session: Mini oral session: NETs and endocrine tumours
Resources:
Slides
Webcast
1145MO - CVM-005: Phase IIa study of CVM-1118, a novel oral anti-vasculogenic mimicry (VM) agent, in advanced neuroendocrine tumors (NET) after progression on prior therapy
Presenter: Chia Jui Yen
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1146MO - Interim analysis of CABONEN: A multicenter phase II trial investigating cabozantinib in patients with advanced, low proliferative NEN G3
Presenter: Alexander Otto Koenig
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1147MO - Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): An AIO phase II multicenter single-arm study
Presenter: Sebastian Krug
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1148MO - A multivariate efficacy analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 study
Presenter: Marianne Pavel
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1149MO - Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumours and carcinoid syndrome: A retrospective experience of two centers of excellence
Presenter: Laura Algeri
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 1148MO and 1149MO
Presenter: Sara De Dosso
Session: Mini oral session: NETs and endocrine tumours
Resources:
Slides
Webcast